Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity

Mackwitz, Marcel K. W.; Hesping, Eva; Eribez, Korina; Schoeler, Andrea; Antonova-Koch, Yevgeniya; Held, Jana; Winzeler, Elizabeth A.; Andrews, Katherine T.; Hansen, Finn K.

dc.contributor.author	Held, Jana
dc.date.accessioned	2022-03-08T07:31:53Z
dc.date.available	2022-03-08T07:31:53Z
dc.date.issued	2021
dc.identifier.issn	1768-3254
dc.identifier.uri	http://hdl.handle.net/10900/125288
dc.language.iso	en	de_DE
dc.publisher	Elsevier France - Editions Scientifiques Medicales Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejmech.2020.113065	de_DE
dc.subject.ddc	540	de_DE
dc.title	Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_02037
utue.personen.roh	Mackwitz, Marcel K. W.
utue.personen.roh	Hesping, Eva
utue.personen.roh	Eribez, Korina
utue.personen.roh	Schoeler, Andrea
utue.personen.roh	Antonova-Koch, Yevgeniya
utue.personen.roh	Held, Jana
utue.personen.roh	Winzeler, Elizabeth A.
utue.personen.roh	Andrews, Katherine T.
utue.personen.roh	Hansen, Finn K.
dcterms.isPartOf.ZSTitelID	European Journal of Medicinal Chemistry	de_DE
dcterms.isPartOf.ZS-Issue	Article 113065	de_DE
dcterms.isPartOf.ZS-Volume	211	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE